🇺🇸 FDA
Pipeline program

-, VALSARTAN AND SACUBITRIL , CARVEDILOL , DAPAGLIFLOZIN , -, RAMIPRIL , -, -, LOSARTAN

APHP230833

Phase 3 small_molecule active

Quick answer

-, VALSARTAN AND SACUBITRIL , CARVEDILOL , DAPAGLIFLOZIN , -, RAMIPRIL , -, -, LOSARTAN for Heart failure is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Heart failure
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials